|
 |
| |
| Home > Innovative Products |
| |
|
| |
TRT
Advantage:
- Stem Cell Therapy: Clinical development of HUCPVC Therapy™, a source of non-embryonic stem cells for patient care
- Stem Cell Banking: HUCPVC Storage™ for the long-term storage of patient Umbilical Cord Tissue stem cells collected after the full term birth of your child
- Bone Augmentation: Assisting the natural renewal and remodeling of bone with OsteoScaf™, our macroporous biodegradable scaffold
|
|
| |
| TRT is applying technical and working knowledge of our rich source of stem cells and synthetic scaffold material to advance clinical treatments within the medical community. These technologies are commercialized through various established corporations through product and technology licensing agreements. |
| |
| HUCPVC Therapy™ focuses on a highly proliferating source of Mesenchymal Stem Cells (MSCs) isolated from human umbilical cord. These cells function to create and restore bone, cartilage, fat, muscle, tendon, and ligament in the human body. MSCs control autoimmune and inflammatory diseases. |
| |
| HUCPVC Storage™ centers on the banking of the HUCPVCs after the collection of |
|
|
 |
|
the baby's umbilical cord after birth. This service is provided directly by the licensees
of
TRT technology for the future potential clinical use of these stem cells. Companies that offer this service under exclusive license are Stem Cell Authority Ltd. in the United States, FutureMed Ltd. in the Middle East, and CReATe Cord Blood Bank in Canada. |
| |
| Our OsteoScaf™ scaffold is a unique, fully resorbable 3-phase biomaterial for application and use as a trabecular bone graft. The scaffold aids the natural bone development of broken bone. These characteristics make the OsteoScaf™ polymeric system exclusive in the field.
|
| |
| The HUCPVC Therapy™ partnered with the OsteoScaf™ reveals a very interesting proposition for TRT. By marrying both TRT technologies not only does one compliment the other by allowing HUCPVC stem cells to aid the scaffold with bone growth but it leaves a wealth of opportunities for research and development. |
| |
|
|
|
